Results 281 to 290 of about 113,624 (330)
Spinal muscular atrophy in Brazil: from individual treatment to global management. [PDF]
Servais L, Moreno CAM.
europepmc +1 more source
Real-world evidence in spinal muscular atrophy: addressing heterogeneity of populations and treatment comparisons. [PDF]
Ropars J, Grimaldi L, Quijano-Roy S.
europepmc +1 more source
Cytoskeleton dysfunction of motor neuron in spinal muscular atrophy. [PDF]
Shi T+8 more
europepmc +1 more source
A de novo deletion underlying spinal muscular atrophy: implications for carrier testing and genetic counseling. [PDF]
Zwartkruis MM+14 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2022
Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of SMN leads to loss of α-motor neurons, severe muscle weakness and often early death. Standard-of-care recommendations for multidisciplinary supportive care of SMA were established in the past few
Eugenio Mercuri+4 more
openaire +3 more sources
Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of SMN leads to loss of α-motor neurons, severe muscle weakness and often early death. Standard-of-care recommendations for multidisciplinary supportive care of SMA were established in the past few
Eugenio Mercuri+4 more
openaire +3 more sources